Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 May 2020

Dear Health Sciences applicant
 
At the University of the Free State (UFS), we understand that the current COVID-19 situation is raising many questions for a matriculant who wishes to apply for university study in 2021. We acknowledge the concerns you may have and would like to share important information that should put your mind at ease:
 
1.     The due date for applying to the Faculty of Health Sciences remains 31 May 2020.
 
2.     The following will not be a requirement when applying to study at the UFS in 2021:
 
-          NBT test results
-          Grade 12 June examination results
 
3.     The following is required for application to study at the UFS in 2021 and must accompany your application for admission:
 
-          Grade 11 final examination results  
 
4.     The following supporting documents that you are required to submit together with your application, may be forwarded to FHSApplications@ufs.ac.za at a later stage when the lockdown level makes it possible for you to have these forms completed:
 
-          The school value-added form
-          Confirmation of good health by a medical practitioner
-          Only in the case of applying for Occupational Therapy selection: a motivation (no more than 250 words) can be submitted instead of the proof of a visit to an occupational therapy practice.
 
Therefore, we urge you to apply as soon as possible before the deadline and then send the outstanding documents at a later stage.
 
We look forward to receiving your application to study at Kovsies in 2021!

News Archive

UFS cardiac team does pioneering work
2017-10-29

Description: ' 000 Cardiac Pioneers Tags: Cardiac Pioneers 

“With the use of endomyocardial biopsies, the team hopes to treat viruses unique
to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

Photo: iStock

Members of the University of the Free State’s (UFS) Cardiac team had various achievements at national and international level this year. The Robert WM Frater Cardiovascular Research Centre in the Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.

With an Afrocentric research focus, Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition, and 50% of patients who have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made, where virus infections of the heart muscle, or myocarditis, have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

According to Prof Mokoali Makotoko, Head of the Department of Cardiology, more than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies, the team hopes to treat viruses unique to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

The study is a project that flows from Prof Makotoko’s PhD. The project is being run with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

 "More than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept